NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/12/2025
Voltar para busca
Dado oficial do USPTO
ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK
ST13
US500000086271626Classe
16, 41, 42, 44
Pedido
86271626
Registro
4966469
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
55
Atualização mais recente
30/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
16, 41, 42, 44
Data de depósito
05/05/2014
Data de registro
24/05/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/12/2025
Última transação
30/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Primeiro uso
2014-05-00
Primeiro uso no comércio
2014-05-00
Código do desenho
4
Tipo de titular
03
Localização do titular
Hudson, FL
Examinador
MALASHEVICH, JASON
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
M2GEN, CORP.
M. C. (pessoa física)
Representantes
Karen K. Won Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo P.C.
Classificação técnica
Classes Nice
Classe 16Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 16
Publicationsprinted materialsbrochurespamphletsbulletinsnewsletter and magazines in the field of cancerbioinformatics and biotechnologies
Classe 41
Medical educational and training servicesconducting lecturesseminarsworkshopsconferencesinternshipsfellowshipsresidenciesworkshops in the field of cancer
Classe 42
Medicalclinicalscientific research in the field of cancer; Application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; Scientific and technological servicescollaborative scientific research and development services for researchers in the fields of oncologydevelopment of proprietary bioinformatic analysis software pipelines and computer systems for collectingstoringcharacterizingsortingviewingdelivering medical data and research information to clients; designing genomic experiments in context of client driven strategic goals; providing scientific research dataincluding customproprietary bioinformatic analysis of data generated in the fields of genomics and oncology; data collection for research purposesdata mining and pattern recognitiondesigning clinical studiesgenerating genomic data from patient samples; Data collection for research purposesthe collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies; data collection for research purposesthe collection of mathematical and statistical dataclinical datapatient data and data of clinical studies relating to clinical response to cancer treatments; compiling data for research purposes in the field of medical sciencecompiling patient specific molecular and genomic datapatient specific clinical data and scientific clinical studies; scientific and technological servicesresearch services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of oncology; providing an online database comprised of medicalpharmaceuticalbiological and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medicaltranslational medicineinterventional epidemiologybioinformaticsclinical information technologygenomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of bioinformatics and oncology; design and development of computer software for integration of patient specific datamolecular test resultsclinical studies and scientific results; providing online nondownloadable medical diagnostic and treatment research computer software for use by healthcare professionals; providing an online searchable database for clinical and scientific research in the field of oncology; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic datadrug protocolsclinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic datadrug protocolsclinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting servicesdesigning and conducting clinical studies and selecting patients for clinical studies in the field of cancer therapy for others; Conducting clinical trial matching between patients with cancer and organizations conducting or administering clinical trials in the nature of medical research; technological and scientific data analysis in the field of oncology; scientific and research consulting servicestechnical data collectionresearch analysis and technical reporting of patients' outcomes and resulting prescribing data related thereto in the field of oncology; providing temporary use of non-downloadable scientific research and analysis software in the field of oncology and bioinformatics; Providing a website portal featuring bioinformatic research data and search engine for biomedical data for data mining and pattern recognitionselecting patients for clinical studiesdesigning clinical studiesgenerating genomic data from patient samples in the field of oncology; providing temporary use of non-downloadable bioinformatic software for diagnosing medical conditionspreparing medical dataresearch and reports for data mining and pattern recognitionselecting patient for clinical studiesdesigning clinical studiesgenerating genomic data from patient samples in the field of oncology; technical and scientific data analysis in the field of oncology
Classe 44
Data collection for research purposesproviding medical evaluations of patients to determine acceptability for participation in clinical trials; Providing healthcare counselingscreeningdiagnosisprognosistreatmentrelapsepalliativeintegrative medicinesurvivorshipother related medical information in the field of cancer; Healthcare servicesproviding a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment researchadvising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions
Publicações
Histórico de despachos e eventos da marca no USPTO.
55 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
11/12/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/12/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/12/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
29/08/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
24/05/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/11/2022
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/11/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/11/2022
PUM1
OFFICE ACTION ISSUED POU1
25/05/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/05/2022
ES8R
TEAS SECTION 8 RECEIVED
10/05/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
24/05/2021
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
29/08/2018
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
24/05/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
15/04/2016
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
08/04/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
08/04/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/04/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
08/04/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/04/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/03/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/03/2016
ALIE
ASSIGNED TO LIE
18/03/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/03/2016
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
16/09/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/09/2015
GNRT
NON-FINAL ACTION E-MAILED
15/09/2015
CNRT
NON-FINAL ACTION WRITTEN
15/09/2015
IUAA
USE AMENDMENT ACCEPTED
15/09/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/09/2015
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/09/2015
IUAF
USE AMENDMENT FILED
11/09/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2015
EAAU
TEAS AMENDMENT OF USE RECEIVED
10/09/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/03/2015
GNRT
NON-FINAL ACTION E-MAILED
11/03/2015
CNRT
NON-FINAL ACTION WRITTEN
11/03/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/02/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/02/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/02/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
21/08/2014
GNRT
NON-FINAL ACTION E-MAILED
21/08/2014
CNRT
NON-FINAL ACTION WRITTEN
21/08/2014
DOCK
ASSIGNED TO EXAMINER
19/08/2014
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/06/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/06/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/05/2014
NWAP
NEW APPLICATION ENTERED
08/05/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.